Mario Muñoz Builes

54PUBLICATIONS
299CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Transplantation immunologyInfant and child healthCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (54)

|Sep 30, 2026
Immunotherapy refractoriness and early post-alloHCT relapse define ultra-high-risk B-ALL after CD19 CAR T-cell therapy.

|Sep 22, 2026
Naive T cell-depleted hematopoietic stem cell transplantation to minimize immunosuppression after solid organ transplantation: case report.

|Sep 01, 2026
Establishing a Multicenter Personalized Medicine Program in Childhood, Adolescent, and Young Adult Cancer in Spain: The SEHOP-PENCIL Project.

|Aug 27, 2026
Tisa-cel and axi-cel CAR structure influences the development of resistance to CD19-CAR-T therapy.

|Jun 04, 2026
Landscape Assessment to Characterize Baseline Access and Multilevel Barriers to IMProve Access to Chimeric Antigen Receptor T-Cell CD19 Therapy for Pediatric B-ALL (IMPACT study) Across Europe.

|Feb 27, 2026
NKGD2 Ligands (NKG2DLs) in Breast Cancer: In Silico Analysis and Narrative Review.

Jesús Peña-López, Angelo Gámez-Pozo, Lucía Trilla-Fuertes

Pageof 9

Frequent Collaborators

5 joint publications

Víctor Galán-Gómez

5 joint publications

Adela Escudero López

4 joint publications

Marta González-Vicent

3 joint publications

Beatriz Ruz-Caracuel